Approximately @,@ subjects will be randomized in a @:@:@ ratio to receive either rivaroxaban @ mg once daily plus clopidogrel @ mg daily for @ months ( a WOEST trial-like strategy ) , or rivaroxaban @ mg twice daily ( with stratification to a prespecified duration of DAPT @ , @ , or @ months , an ATLAS trial-like strategy ) , or dose-adjusted VKA once daily ( with stratification to a prespecified duration of DAPT @ , @ , or @ months , traditional triple therapy ) .